Your search returned 2 results.

Results
	1.	Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma. [electronic resource] by Moreau, Philippe Karamanesht, Ievgenii I Domnikova, Natalia Kyselyova, Maryna Y Vilchevska, Kateryna V Doronin, Vadim A Schmidt, Alexander Hulin, Cyrille Leleu, Xavier Esseltine, Dixie-Lee Venkatakrishnan, Karthik Skee, Donna Feng, Huaibao Girgis, Suzette Cakana, Andrew van de Velde, Helgi Deraedt, William Facon, Thierry Producer: 20130418 In: Clinical pharmacokinetics vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study. [electronic resource] by Montesinos, Pau Roboz, Gail J Bulabois, Claude-Eric Subklewe, Marion Platzbecker, Uwe Ofran, Yishai Papayannidis, Cristina Wierzbowska, Agnieszka Shin, Ho Jin Doronin, Vadim Deneberg, Stefan Yeh, Su-Peng Ozcan, Mehmet Ali Knapper, Steven Cortes, Jorge Pollyea, Daniel A Ossenkoppele, Gert Giralt, Sergio Döhner, Hartmut Heuser, Michael Xiu, Liang Singh, Indrajeet Huang, Fei Larsen, Julie S Wei, Andrew H Producer: 20210113 In: Leukemia vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)